March 28, 2012
Ver artículo completoDiabetic Retinopathy
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
The incidence of diabetes is increasing, but that of diabetic retinopathy is falling, probably owing to better management of glucose levels, lipid abnormalities, and hypertension. Clinical trials of VEGF and PPAR-α inhibitors are improving vision and providing insights into pathogenesis.
Cite This Study
Antonetti et al. (Wed,) studied this question.